Our Top Stories of 2021
Clinical Lab Manager | Dec 09, 2021
From leadership and management to COVID-19 and cancer, explore Clinical Lab Manager's most read stories of 2021
Urinalysis
Liquid Biopsies May Aid Diagnosis, Treatment of Bladder, Nerve Tumors
Washington University School of Medicine | Sep 02, 2021
Blood, urine biopsies could pave way for more personalized cancer therapy
Skipping Urine Test Leaves High-Risk Groups with Untreated Kidney Disease
Johns Hopkins University Bloomberg School of Public Health | Aug 20, 2021
Large study suggests that urine test for detecting chronic kidney disease is not used enough in high-risk groups
Preoperative Screening Urinalysis Is Widely Used—but Usually Unnecessary
Massachusetts General Hospital | Aug 03, 2021
Reducing Invasive Biopsies in Prostate Cancer
Miriam Bergeret, MSc | Jul 14, 2021
A new experimental urine test for prostate cancer may reduce the number of unnecessary biopsies
Innovative Automated Urinalysis
Scott D. Hanton, PhD | Jul 09, 2021
Automation can provide a solution to the biggest challenges in urinalysis testing
Infographic: The Future of Prostate Cancer Biomarkers Is Multiplexed
Oreoluwa Ogunyemi, MD | Jul 07, 2021
Combining urinary biomarkers improves clinical utility and provides a more robust evaluation
Urine Biomarkers Show Promise for Prostate Cancer
Oreoluwa Ogunyemi, MD | Jul 06, 2021
More clinically accurate biomarkers could help prevent unnecessary prostate biopsies
Can Cell-Free DNA in Urine Be Used to Detect Cancer?
The Translational Genomics Research Institute | Feb 19, 2021
Study confirms that cell-free DNA in urine can differentiate between healthy individuals and those with cancer
Lipid Biomarkers in Urine Can Determine the Type of Asthma
Karolinska Institutet | Jan 20, 2021
The results lay the foundation for personalized diagnoses, which may improve treatment of severe asthma